Publication | Closed Access

Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage

Neurological DisorderImmunologyBlood-brain Barrier DamageSocial SciencesNeuroinflammationInflammationNeurobiology Of DiseaseCerebrospinal FluidNeurologyActive Multiple SclerosisNeuroimmunologyAutoimmune DiseaseBrain-immune InteractionImmune FunctionCerebral Blood FlowNeurological AssessmentNeuroscienceMultiple SclerosisMedicine